Light therapy vs vitamin D cream for oral leukoplakia
Part of Cancer, Mouth & dental clinical trials.
This study compares two topical treatments for oral leukoplakia, a white patch in the mouth that can become cancer. One treatment uses light-activated therapy (photodynamic therapy), and the other uses a vitamin D cream (calcipotriol).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of oral leukoplakia, which is a white patch inside the mouth that can become cancerous.
- The patch must be at least 2 square centimeters in size (about the size of a postage stamp).
- You must be 18 years of age or older.
- You must be willing to attend all treatment sessions and follow the study plan.
- You cannot have had any treatment for this condition (topical or systemic) in the last 2 months.
- You must not have a history of cancer, severe dysplasia (precancerous cells), or carcinoma in situ in the mouth.
- You must not have conditions that make you overly sensitive to light, calcium/vitamin D problems, or be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a cream containing coenzyme Q10 and curcumin can help treat a common mouth condition called oral leukoplakia (a white patch that can sometimes turn into cancer). It is for people with a specific type of white patch that is not severe and can be easily reached with a cream.
This trial tests a low-cost light therapy to treat precancerous mouth lesions (moderate to severe dysplasia or carcinoma in situ) that are at least 10 mm. The treatment uses a special light to destroy abnormal cells, possibly avoiding surgery.
This study looks at oral leukoplakia (persistent white patches in the mouth) to better predict which ones may develop into cancer. It uses a test based on specific immune and cancer-related markers to help estimate each person’s risk.
This study tests if metformin — a medication commonly used for diabetes — can prevent oral leukoplakia from turning into cancer when applied as a mouth rinse and taken as a pill. It is for people with non-severe white patches in the mouth.
This trial studies whether a two-medicine diabetes drug combination can reduce or control risky early changes in certain mouth and throat lesions. You may be asked for small tissue samples (biopsies) before and after 12 weeks to see how the lesions respond.
This trial tests two light-based treatments (photobiomodulation and photodynamic therapy) and a steroid cream (clobetasol) for painful oral lichen planus. The goal is to see which treatment works best to reduce mouth sores and discomfort.
Hear when a new Oral Leukoplakia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.